A detailed history of Kennebec Savings Bank transactions in Novartis Ag stock. As of the latest transaction made, Kennebec Savings Bank holds 5,098 shares of NVS stock, worth $670,641. This represents 0.6% of its overall portfolio holdings.

Number of Shares
5,098
Previous 5,445 6.37%
Holding current value
$670,641
Previous $659 Million 0.78%
% of portfolio
0.6%
Previous 0.65%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

SELL
$113.5 - $129.73 $39,384 - $45,016
-347 Reduced 6.37%
5,098 $654 Million
Q2 2025

Jul 21, 2025

SELL
$101.96 - $121.01 $25,388 - $30,131
-249 Reduced 4.37%
5,445 $659 Million
Q1 2025

Apr 14, 2025

BUY
$97.14 - $115.57 $40,021 - $47,614
412 Added 7.8%
5,694 $635 Million
Q4 2024

Jan 23, 2025

SELL
$96.78 - $117.18 $9,678 - $11,718
-100 Reduced 1.86%
5,282 $524 Million
Q3 2024

Nov 04, 2024

BUY
$106.13 - $120.89 $571,191 - $650,629
5,382 New
5,382 $619 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kennebec Savings Bank Portfolio

Follow Kennebec Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennebec Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Kennebec Savings Bank with notifications on news.